Despite economic challenges due to COVID-19 shutdowns, the Parkinson’s Foundation is investing $10 million toward research, its care network, and community grants, the CEO of the ... Read more
New Rasagiline Formulation May Allow Application to SkinA new formulation of rasagiline, approved for Parkinson’s disease, may allow the therapy to be given by applying it to the skin. The treatment’s new ... Read more
CEPT Cocktail Protects Stem Cells in Lab, Opening Research PossibilitiesA four-ingredient, small-molecule cocktail was seen to protect stem cells from the stresses of lab work better than existing agents, helping to preserve their normal ... Read more
Salivary Caffeine Levels Decreased in Some PatientsPeople with moderate or advanced Parkinson’s disease have abnormally low levels of caffeine in their saliva, despite normal caffeine metabolism, a new study indicates. The ... Read more
STAR Candidates Boost GCase in Cell, Animal ModelsGain Therapeutics‘ investigational compounds were able to lessen motor symptoms in a rat model of GBA1-associated Parkinson’s disease and also decrease the levels of alpha-synuclein ... Read more
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
A new tool called cardiopulmonary coupling could be used to effectively evaluate sleep quality in Parkinson’s disease patients, who often experience sleep disorders, according to a study. The study, “Assessment of sleep quality using cardiopulmonary coupling analysis in patients with Parkinson’s ... Read more